The Human Behavioral Pharmacology Subprogram

Research Interests of Core Human Behavioral Pharmacology Faculty

Major Areas of Clinical Research

The Human Behavioral Pharmacology Laboratory (HBPL) is a research unit of the Department of Psychiatry that studies environmental and pharmacological factors that influence drug abuse and diverse new treatments for drug abuse. Our research spans alcohol, amphetamines, benzodiazepines, cannabinoids, caffeine, cocaine, nicotine, and opioids. Research includes:

• clinical research on behavioral and pharmacological treatments for cocaine, nicotine, opiate, alcohol and marijuana dependence.
• human laboratory research identifying behavioral mechanisms of drug dependence.
• examining the behavioral effects of abused drugs.

Sarah Heil	Title	Research Assistant Professor of Psychology Research Assistant Professor of Psychiatry
	Ph.D.	Dartmouth College, 1997
	Focus	Drug abuse treatments for pregnant and postpartum women, including behavioral treatments such as contingency management and pharmacological treatments such as opioid replacement therapies
Stephen Higgins	Title	Professor of Psychology Professor of Psychiatry
	Ph.D.	University of Kansas, 1983
	Focus	Behavioral interventions for cocaine dependence, applications of contingency management in drug-abusing populations, non-pharmacological factors and drug self-administration
	Duties	Director, Substance Abuse Treatment Center Director, Human Behavioral Pharmacology Laboratory Director, Behavioral Pharmacology of Drug Dependence Training Program
John Hughes	Title	Professor of Psychology Professor of Psychiatry Professor of Family Practice
	M.D.	Univ. of Mississippi Medical School, 1975
	Focus	Pharmacological and behavioral treatments for smokers who want to stop, and harm reduction interventions for smokers who are not trying to stop
Stacey Sigmon	Title	Research Assistant Professor of Psychology Research Assistant Professor of Psychiatry Adjunct Assistant Professor, Dartmouth Medical School
	Ph.D.	University of Vermont, 2002
	Focus	Behavioral and pharmacological treatment of opioid dependence; Novel formulations of pharmacotherapies for opioid dependence; Smoking cessation among opioid-dependent patients using a behavioral approach; Laboratory models for understanding the interactions between stimulant medications, including nicotine, cocaine, d-amphetamine and methylphenidate; Behavioral treatments of substance use/abuse among individuals with serious mental illness
	Duties	Director, The Chittenden Clinic

Last modified June 13 2012 01:48 PM